In epidemiologic research, there is no standard approach for accounting for gestational age (GA) at birth when interpreting postnatal anthropometric data in analyses of cohorts that include children born preterm (CBP). A scoping review was conducted to describe analytical approaches to account for GA at birth when applying the WHO Growth Standards (WHO-GS) to anthropometric data in epidemiologic studies. We searched PubMed, Scopus, MEDLINE, Embase, and Web of Science for studies that applied WHO-GS, included CBP in the study population, had access to data within 1 mo of age, and were published between 2006 and 2015 in English. Of the 80 included studies that used the WHO-GS, 80% (64 of 80) included all children regardless of GA, whereas 20% (16 of 80) restricted analyses that used WHO-GS to term-born children. Among the 64 studies that included all children, 53 (83%) used chronological age and 11 (17%) used corrected age for CBP. Of the 53 studies that used chronological age, 12 (23%) excluded data that were likely contributed by CBP (e.g., very low birth weight or extremely low outlying z scores) and 19 (36%) adjusted for or stratified by GA at birth in regression analyses. In summary, researchers commonly apply WHO-GS to CBP, usually based on chronological age.
Introduction
The WHO Growth Standards (WHO-GS) 8 are the most widely accepted international normative basis for evaluating child growth (1) . Adopted in 125 countries, the WHO-GS are based on longitudinal studies (#2 y of age) and cross-sectional studies (2-5 y of age) of a multiethnic sample of term-born (between 37 and 41 wk gestation) children who were exclusively breastfed for at least 4 mo and lived in favorable socioeconomic conditions with no known health or environmental restrictions on growth (2) . The WHO-GS are the only internationally accepted standards depicting optimal post-term patterns of growth of children worldwide (3) . Although a small proportion of term-born lowbirth-weight infants (over 1500 g but below 2500 g) were included, children born preterm (CBP), defined as births that occur before 37 wk gestation, were excluded from the cohort of children used to construct the WHO-GS (2) .
Globally, 11.1% of all live births are CBP (4) . In 2010, ;14.9 million infants were born preterm across 184 countries, with an estimated preterm proportion of total live births ranging from 7.2% in Eastern Asia to ;13% in Southern Asia and SubSaharan Africa (4) . Yet there are no published international standards analogous to the WHO-GS for evaluating growth of CBP in the post-term period (i.e., after 40 wk postmenstrual age). Growth references currently available to evaluate postnatal growth of preterm infants (5) do not typically extend more than a few weeks beyond term age. Therefore, clinical guidelines from several national authorities (6) (7) (8) recommend that clinicians apply the WHO-GS to CBP after reaching term age by correcting the childÕs chronological age for gestational age (GA) at birth, until at least 2 y of chronological age. The correction is calculated by subtracting the difference between term birth (40 wk) and the GA at birth from the childÕs chronological age since birth, all measured in completed weeks.
In contrast to clinical practice, epidemiology lacks standard methods to account for GA at birth in the analysis and interpretation of postnatal anthropometric data and growth outcomes. This consideration is particularly relevant to studies that include children born at a range of term and preterm GAs (for example, birth cohort studies or prenatal intervention trials), because GA at birth has substantial implications for postnatal growth trajectories. In this study, we aimed to describe the methodological approaches that researchers have reportedly used in applying the WHO-GS to children born at varying GAs in recent epidemiological studies.
Methods
A scoping review methodology was employed to map and describe the approaches used by researchers in the application of the WHO-GS in population-based analyses of growth of children born at varying GAs. We identified relevant studies from electronic databases with the use of 2 search strategies ( Figure 1) . Initially, eligible studies published between 1 January 2006 (the year in which the WHO-GS were released) and 30 March 2013 were identified in the peer-reviewed literature by searching the PubMed, MEDLINE, Embase, and Scopus databases. Search terms were used to retrieve primary research articles in which anthropometric measurements of CBP were described or analyzed with the use of the WHO-GS, specifically in randomized controlled trials (RCTs) or cohort studies, with the following search criteria: (''randomized controlled trials'' OR ''cohort studies'') AND ''infant*'' AND ''grow*'' AND ''WHO standards.'' A more generalized search including terms such as (''randomized controlled trials'' OR ''cohort'') AND ''anthropometry'' AND ''infant*'' was also conducted in PubMed and Scopus to improve the sensitivity of the search.
Informed with the results of the initial searches, we subsequently conducted a systematic search of the literature with the use of comprehensive keywords for the target population, anthropometric measurements, and the WHO-GS in the PubMed, MEDLINE, Embase, Web of Science, and Scopus databases (Supplemental Table 1 ). Articles were eligible for inclusion if they reported primary research findings (individual-level analyses); were published in English in peer-reviewed journals between 1 January 2006 and 20 May 2015; included children for whom data were available from within 1 mo of birth (e.g., birth cohorts, follow-up of prenatal intervention trials, longitudinal cohorts); and used the WHO-GS in the analysis of anthropometric measurements for children <5 y of age. We only included studies in which it appeared that investigators had the opportunity to include children born across a range of GAs (including preterm) in the analyses of anthropometric data. Studies in which the source population from which study participants were recruited was restricted explicitly to term-born children were not included in this review. Unless otherwise specified by the study authors, birth cohort studies were assumed to have CBP in the source population and were included in this review. Additionally, we further limited the review to studies for which at least some data were routinely obtained within 1 mo of birth, because these studies would likely have had access to information about GA at birth. Methods papers, review articles, conference abstracts, and commentaries were excluded.
Study eligibility assessment and data abstraction were performed in duplicate by 2 reviewers. In cases in which the 2 reviewers were not able to reach a consensus, a third reviewer resolved the discordance. Data abstraction forms were developed by the review authors to capture information on the study design, sample size, country of data collection, age at first application of the WHO-GS, general characteristics of children in the study, reported summary measures for GA at birth (if any), anthropometric variables measured (i.e., attained z scores) and derived (e.g., change in z scores, conditional growth z scores), and any FIGURE 1 Study selection process.
reported analytical strategy employed in the analysis of child growth with the use of the WHO-GS.
Each article accepted for inclusion in the review was categorized as one of the following:
1) RCT of a prenatal intervention: Studies in which children born to pregnant women enrolled in a prenatal intervention trial were subsequently enrolled in an observational follow-up;
2) RCT of a neonatal intervention: Studies in which neonates were recruited at or within 1 mo of birth and randomly assigned to intervention arms (e.g., infant feeding trials);
3) Pregnancy cohort: Studies in which children born to women in an observational prospective cohort were included for follow-up after delivery; 4) Birth cohort: Studies in which children were enrolled in an observational cohort study starting at or within 1 mo of birth; and 5) Other cohort: Studies in which children were identified by an event other than birth, with birth anthropometric data collected retrospectively. These studies included both prospective and retrospective cohorts, as well as case-cohort studies and school-based cohorts.
Data were abstracted with the use of standard forms that focused specifically on the data management and statistical approaches that may have addressed (deliberately or not) the heterogeneity in GA at birth in relation to analyses of anthropometric measurements and patterns of growth. We expected to find 2 mutually exclusive approaches to deliberately account for GA when applying the WHO-GS: 1) restricting the study sample to term-born children, or 2) assigning z scores based on corrected age (CA) rather than chronological age.
Other data management or statistical approaches that may have intentionally or unintentionally addressed heterogeneity in GA in the application of the WHO-GS were aggregated as ''other'' for the primary analysis. We anticipated a range of approaches in this subgroup, including exclusion of outlying z scores, GA stratification or adjustment in regression-based analysis, and nonparametric methods (e.g., robust regression). For each article, we also noted whether the authors explicitly acknowledged the challenges or limitations of applying the WHO-GS to CBP.
Results
A total of 2559 records were retrieved from electronic databases with the use of a 2-stage search strategy. Of these, 80 articles were deemed eligible and included in this review (Figure 1) . A detailed summary of each article can be found online (Supplemental Table 2 ) (9-88). Most of the studies (66%) included in this review were conducted in low-and middle-income countries, and most (72%) were published in 2010 or later ( Table 1) . One-half of the included studies were longitudinal birth cohorts or observational follow-up studies of prenatal intervention trials, and 80% first applied the WHO-GS to anthropometric data obtained in the neonatal period. A minority of studies (40%) reported the proportion of CBP in the cohort and only 20% reported the lower limit of the observed GA range.
Overall, 16 studies (20%) restricted analyses to children born at or beyond term and 11 studies (14%) used CA when applying the WHO-GS ( Table 1 ). Studies that restricted analyses to termborn children were primarily conducted in North American (50%) populations ( Figure 2) . Two of the studies that restricted the application of the WHO-GS to term-born children did so to evaluate the applicability of the WHO-GS to specific countries [China (30) and South Africa (55)]. Notably, 10 of 11 studies that used CA were facility-based studies that enrolled cohorts restricted to CBP. Only one study reported the use of CA in the context of a mixed cohort of term-and preterm-born children (28) .
Of the 53 studies that used chronological age to plot anthropometric measurements in a mixed cohort of term and pretermborn participants, 23% (12 of 53) used data management strategies that may have partially accounted for heterogeneity in GA at birth within the study population ( Table 2) . Among studies that adjusted for GA or preceding anthropometric measures (19 of 53; 36%), 38% (7 of 19) included birth anthropometry as a covariate in multivariable regression analyses of postnatal growth outcomes. A few studies reported the use of complex growth models, such as conditional growth models (8%; 4 of 53), latent growth curve analysis (4%; 2 of 53), and growth mixture models (2%; 1 of 53). None of the studies reported the use of nonparametric methods, such as robust regression, to account for high-leverage values or outlying z scores resulting from the application of the WHO-GS to CBP. Two studies (61, 87) used WHO Growth Velocity Standards in addition to the WHO-GS for attained growth to evaluate postnatal growth in their study population.
It was rarely feasible to determine from published articles whether data management/analysis approaches were adopted specifically and intentionally to account for heterogeneity in gestational duration of children in the population or potential misclassification of CBP with the use of the WHO-GS. We determined that only 12 of 80 (15%) studies explicitly acknowledged the limitations or implications of applying the WHO-GS to CBP. Importantly, all of these 12 studies either restricted analyses to term-born children or used CA in the application of the WHO-GS. Inferences were essentially unchanged in sensitivity analyses that were 1) restricted to studies that were retrieved from the systematic search only, and 2) restricted to the most recent publication from each research group (Supplemental Table 3 ).
Discussion
Fetal and early childhood growth is a critical determinant of health and disease in later life and therefore a common target of epidemiologic research (91) (92) (93) . Birth marks an important event in the continuum of somatic growth, as its timing substantially affects a childÕs ex utero growth trajectory. Healthy FIGURE 2 Strategies used to address heterogeneity in GA at birth in studies of child growth that included children born preterm, by geographical region (n = 80). ''Corrected age'' refers to age corrected for GA at birth [chronological age -(40 wk -GA at birth)]. ''Other'' includes any study included in this scoping review that did not restrict the analyzed cohort to either term-born children or correct age for GA at birth when evaluating postnatal growth with the use of the WHO-GS. These studies may have reported the use of other data management or analytical strategies to address heterogeneity in GA at birth (see Table 2 ). GA, gestational age; WHO-GS, WHO Growth Standards.
TABLE 1
Characteristics of studies included in a scoping review of the application of the WHO-GS in epidemiologic studies of populations that included preterm-born children, overall and by major method used to account for heterogeneity in GA at birth 1 All studies (n = 80) (61) 12 (75) 11 (100) 26 (49) Antenatal/prenatal care clinic 9 (11) 1 (6) 1 (9) 7 (13) Neonatal intensive care unit 9 (11)
58 (73) 9 (56) 5 (45) 50 (94) preterm-born children are smaller at birth than their term-born counterparts, often experience a period of early postnatal growthfaltering (relative to fetal growth rates), and then typically demonstrate a prolonged phase of catch-up growth (upward crossing of z scores) in the post-term age period (relative to term-born children) (43, 94 ). Yet, in this scoping review, we found that only a minority of investigators deliberately accounted for GA at birth when applying the WHO-GS to analyses of postnatal anthropometric data, by either restricting the analysis to term-born children or using CA in the application of the WHO-GS to CBP. In contrast to conventional clinical practice, most studies used chronological ages when determining the age-and sex-standardized z scores of children, regardless of the GA at birth. There were a range of reported approaches applied in analyses of anthropometric data when using chronological age, including data cleaning rules (e.g., exclusion/ truncation of outlying raw anthropometry or z scores) and regression methods (e.g., inclusion of GA as a covariate in multivariable models). However, there was limited evidence to suggest that researchers commonly used these methods deliberately to overcome the methodological pitfalls of using the WHO-GS to describe the growth of CBP using chronological age. Data cleaning and/or regression-based methods to account for GA are unlikely to overcome the inferential errors that arise from plotting the growth of CBP on the WHO-GS curves using chronological age (i.e., elapsed time since birth) instead of postmenstrual age (i.e., elapsed time since last menstrual period). For example, plotting the serial lengths of a female infant born at 30 wk gestation on the chronological age timescale (Figure 3, panel A) may result in length z scores that are well below the normal distribution and could suggest rapid catch-up growth in the early postnatal period. An interpretation that does not take GA at birth into account may lead to the classification of attained anthropometric measures of CBP as extreme negative outliers and/or biologically implausible values. Indeed, the publicly available WHO-GS Anthro macro for deriving age-and sex-standardized scores (z scores) from raw anthropometric data specifically flags observations below 26 SDs for length-and weight-for-age measures and below 25 SDs for other anthropometric outcomes (e.g., weight-for-height and BMI-for-age) as biologically implausible values (90), causing them to be missing in some analyses. Regression modelbased strategies (e.g., including GA at birth as a covariate in a multivariable model) may be inappropriate if gestational duration is on the causal pathway between the exposure and outcome of interest (95), rendering the analysis prone to a type of selection bias referred to as ''collider-stratification bias'' (96) ( Table 3) . Complex statistical models, including conditional growth models and latent growth curve analysis, may be used to account for the heterogeneity in GA (by using random effect/ random slope models); however, unless explicitly specified by the investigators, these methods do not estimate the heterogeneity in individual growth trajectories attributable to variability in gestational duration. The lack of comparability of growth trajectories among children born at varying GAs remains a barrier to making population-level inferences about the determinants of early infant growth patterns.
Among the studies that accounted for GA at birth in the analysis of anthropometric data, the most straightforward approach was to restrict the analysis to term-born participants. This approach mirrors the WHO-GS Multicentre Growth Reference Study population and essentially eliminates analytical challenges caused by the differential growth patterns of CBP relative to term-born children (Table 3) . However, this approach limits the generalizability of the study findings to term-born populations, and still does not account for the heterogeneity in size at birth within the 5 wk period conventionally considered as term. Conversely, using CA when analyzing anthropometric data in epidemiologic studies has several potential advantages (Table 3) . This approach has a sound biological basis, enables inclusion of all infants across the full GA range, may reduce the frequency of influential outliers and biologically implausible z scores [as cited by several studies in this review (25, 50, 78) ], and is in line with the conventional practice in clinical research that largely prevents the mislabeling of post-term age growth patterns of CBP (54, 97) . However, correcting for GA at birth when applying the WHO-GS to CBP in epidemiologic studies gives rise to 3 analytical issues that should be considered by researchers, although they may not be directly relevant in clinical practice (Figure 3) . First, using CA may lead to the loss of anthropometric data before the 40 wk postmenstrual age, a period in which the WHO-GS cannot be applied (Figure 3, panels A and  B) . In studies in which the effect of a prenatal exposure is hypothesized to occur in the peripartum or early postnatal period, or in those in which the exposure of interest may affect GA at birth, loss of data in the early postnatal period may induce selection bias because of a differential pattern of missingness in exposed compared with unexposed groups. Second, when CA is used in the application of the WHO-GS, careful consideration must be given to the potential disruption of the temporal lag between an exposure and outcome ( Figure 3 and Table 3 ). In most analyses, the CA would not be the appropriate timescale for analysis of exposure-outcome associations. Third, the researcher must decide whether the analysis should incorporate a correction of the ages of CBP only (as in clinical practice) or the entire cohort (i.e., including corrections for GAs of 37-39 and 41-42 wk). Applying the correction only to CBP in epidemiologic studies may not fully account for the effect of GA at birth on inferences related to anthropometric data ( Figure 3 , panels B and C).
The magnitude of bias caused by applying the WHO-GS to CBP with the use of chronological age would be expected to depend on the distribution of GAs at birth and the proportion of CBP in the population (i.e., bias would increase as the proportion of CBP increases), as well as the nature of the research question; for example, the bias is likely to be relatively large for studies focused on the early postnatal growth rate (within the first months of life), but minimal for studies in which the WHO-GS are applied beyond infancy. A potential comprehensive strategy to circumvent the challenges posed by CBP in the application of the WHO-GS may be to 1) use the CA timescale to ascertain z scores for all children up to at least 2 y of age, irrespective of term/preterm classification; 2) use the chronological timescale for exposure-outcome association analyses; and 3) adopt a population-based, ethnically-diverse neonatal anthropometric size reference, such as the Fenton curves (98) or the INTERGROWTH-21st (International Fetal and Newborn Growth Consortium for the 21st Century) newborn size standards (99) , to assign z scores in the preterm period. The newborn size standards from the INTERGROWTH-21st Study for infants born at varying GAs in geographically diverse populations (99) overcome several limitations of growth references previously available (5, 100); however, the utility of these references in epidemiologic studies may be limited, because they do not extend below 33 wk gestation. Preterm postnatal growth standards based on the Preterm Postnatal Follow-up of the INTERGROWTH-21st study population-those born between 26 and <37 wk gestation from birth until 64 wk postmenstrual age (101)-may be a useful tool to interpret the post-term growth of CBP, but have not been published at the time of writing. The alignment of these standards with the WHO-GS, and the methodological implications of using multiple growth standards in pooled analyses, warrants further discussion and evaluation. Currently, the Fenton curves are widely used in clinical practice, and have the advantage of extending from early GA through to the early post-term period, connecting smoothly to the WHO-GS by 50 wk postmenstrual age (98) .
The findings of this review must be interpreted in the context of the reviewÕs limitations. We used a scoping review methodology to strike a balance between comprehensiveness and breadth of the search criteria with feasibility of the review (102); we therefore have identified a sample of epidemiologic studies in which CBP were included in the study population. Scoping studies are used to rapidly map the existing literature or evidence base within a research field to ''examine the extent, range, and nature of [the] research activity'' (102, 103) . These reviews are methodologically similar to systematic reviews, but differ in that they typically employ a broad research question and are less reliant on quantitative data synthesis (104) . The inclusion criteria applied in the selection of studies for this review were determined pragmatically and based on our best judgement. We assumed a priori that the methodological implications of heterogeneity in GA when evaluating growth would be most relevant to researchers studying cohorts that included CBP. The consistency of inferences from studies retrieved through the 2 complementary search strategies and throughout the publication years suggests that our conclusions with respect to analytical strategies employed in the application of the WHO-GS to CBP are likely to be unbiased and current. We also did not conduct a risk of bias assessment of studies, because the objective of this review was inherently methodological in nature. Finally, it is important to note that conceptual and methodological challenges posed by CBP can only feasibly be addressed in studies that collect or have access to GA data; in studies in which these data are not collected, the potential implications of applying the WHO-GS to CBP are necessarily ignored.
In conclusion, there is a lack of consensus regarding the analysis of postnatal anthropometric data in epidemiologic studies that include both term-and preterm-born children. We found that researchers commonly apply the WHO-GS to CBP with the use of chronological age without acknowledging the important conceptual and methodological limitations of this decision. Further efforts are required to define acceptable analytic approaches to the application of postnatal growth standards in analyses of cohorts that include children born across the full range of GAs.
